Cytogenetic and FMS-like tyrosine kinase 3 mutation analyses in acute promyelocytic leukemia patients.

about

P2860

Q42349214-92282836-F97D-44A2-AE7C-C464ED2621E7

P2860

Cytogenetic and FMS-like tyrosine kinase 3 mutation analyses in acute promyelocytic leukemia patients.

Item

http://www.wikidata.org/entity/Q36734284

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Cytogenetic and FMS-like tyros ...... omyelocytic leukemia patients.

@ast

Cytogenetic and FMS-like tyros ...... omyelocytic leukemia patients.

@en

type

Item

label

Cytogenetic and FMS-like tyros ...... omyelocytic leukemia patients.

@ast

Cytogenetic and FMS-like tyros ...... omyelocytic leukemia patients.

@en

prefLabel

Cytogenetic and FMS-like tyros ...... omyelocytic leukemia patients.

@ast

Cytogenetic and FMS-like tyros ...... omyelocytic leukemia patients.

@en

P1476

Cytogenetic and FMS-like tyros ...... omyelocytic leukemia patients.

@en

P2093

Ardeshir Ghavamzadeh

http://www.w3.org/2001/XMLSchema#string

Hossein Mozdarani

http://www.w3.org/2001/XMLSchema#string

Kamran Alimoghaddam

http://www.w3.org/2001/XMLSchema#string

Marjan Hajhashemi

http://www.w3.org/2001/XMLSchema#string

Marjan Yaghmaie

http://www.w3.org/2001/XMLSchema#string

Mozaffar Aznab

http://www.w3.org/2001/XMLSchema#string

Seyed H Ghaffari

http://www.w3.org/2001/XMLSchema#string

P2860

The role of FLT3 in haematopoietic malignancies

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.

RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years.

A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis.

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease.

Molecular genetics of human leukemias: new insights into therapy.

Class III receptor tyrosine kinases: role in leukaemogenesis.

P304

10-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22562027

http://www.w3.org/2001/XMLSchema#string

P932

3614257

http://www.w3.org/2001/XMLSchema#string

Cytogenetic and FMS-like tyrosine kinase 3 mutation analyses in acute promyelocytic leukemia patients.

about

P2860

P2860

Cytogenetic and FMS-like tyrosine kinase 3 mutation analyses in acute promyelocytic leukemia patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932